The ERA Registry Annual Report 2019 : summary and age comparisons
Boenink, Rianne (University of Amsterdam, Amsterdam, The Netherlands)
Astley, Megan E. (University of Amsterdam, Amsterdam, The Netherlands)
Huijben, Jilske A. (University of Amsterdam, Amsterdam, The Netherlands)
Stel, Vianda S. (University of Amsterdam, Amsterdam, The Netherlands)
Kerschbaum, Julia (Medical University Innsbruck, Innsbruck, Austria)
Ots-Rosenberg, Mai (Tartu University Hospital (Tartu, Estònia))
Åsberg, Anders A. (Oslo University Hospital (Oslo, Noruega))
Lopot, Frantisek (General University Hospital, Prague-Strahov, Czech Republic)
Golan, Eliezer (7Israel Renal Registry, Ramat Gan, Israel)
Castro de la Nuez, Pablo (Sistema de Información de la Coordinación Autonómica de Trasplantes de Andalucía (SICATA))
Rodríguez Camblor, Marta (Registro de Enfermos Renales Crónicos de Asturias (RERCA))
Trujillo-Alemán, Sara (Servicio Canario de la Salud, Islas Canarias)
Ruiz San Millan, Juan Carlos (Universidad de Cantabria)
Ucio Mingo, Pablo (Dirección General de Planificación y Asistencia Sanitaria, Valladolid)
Díaz Gómez, Juan Manuel (Institut d'Investigació Biomèdica Sant Pau)
Bouzas-Caamaño, M. Encarnación (Servicio Gallego de Salud)
Artamendi, Marta (Hospital San Pedro, Logroño, La Rioja)
Aparicio Madre, Manuel I (Oficina Regional de Coordinación de Trasplantes, Region de Madrid)
Santiuste de Pablos, Carmen (Consejo de Salud de la Región de Murcia)
Slon Roblero, María Fernanda (Complejo Hospitalario de Navarra)
Zurriaga, Oscar (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública)
Stendahl, Maria E. (Jonkoping Regional Hospital, Jonkoping, Sweden)
Bell, Samira (University of Dundee, Dundee, UK)
Idrizi, Alma (UHC Mother Teresa, Tirana, Albania)
Ioannou, Kyriakos (Cyprus Renal Registry, Nicosia, Cyprus)
Debska-Slizien, Alicja (Gdansk Medical University, Gdansk, Poland)
Galvão, Ana A. (Portuguese Society of Nephrology, Coimbra, Portugal)
De Meester, Johan (Dutch-speaking Belgian Renal Registry (NBVN), Sint-Niklaas, Belgium)
Resić, Halima (Society of Nephrology and Dialysis of Bosnia and Herzegovina, Sarajevo, Bosnia and Herzegovina)
Hommel, Kristine (Holbæk Hospital (Dinamarca))
Radunovic, Danilo (Clinical Center of Montenegro, Podgorica, Montenegro)
Pálsson, Runolfur (Landspitali University Hospital (Reykjavík, Islàndia))
Lassalle, Mathilde (Agence de la Biomédecine, Saint-Denis La Plaine, France)
Finne, Patrik (Helsinki University Hospital (Finlàndia))
García Bazaga, María de los Ángeles (Servicio Extremeño de Salud)
Gjorgjievski, Nikola (University Hospital of Nephrology, Skopje, North Macedonia)
Seyahi, Nurhan (University-Cerrahpasa, Istanbul, Turkey)
Bonthuis, Marjolein (University of Amsterdam, Amsterdam, The Netherlands)
Ortiz, Alberto (Universidad Autónoma de Madrid)
Jager, Kitty J. (University of Amsterdam, Amsterdam, The Netherlands)
Kramer, Anneke (University of Amsterdam, Amsterdam, The Netherlands)
Universitat Autònoma de Barcelona

Fecha:	2021
Resumen:	Data on renal replacement therapy (RRT) for end-stage renal disease were collected by the European Renal Association (ERA) Registry via national and regional renal registries in Europe and countries bordering the Mediterranean Sea. This article provides a summary of the 2019 ERA Registry Annual Report, including data from 34 countries and additional age comparisons. Individual patient data for 2019 were provided by 35 registries and aggregated data by 17 registries. Using these data, the incidence and prevalence of RRT, the kidney transplantation activity and the survival probabilities were calculated. In 2019, a general population of 680. 8 million people was covered by the ERA Registry. Overall, the incidence of RRT was 132 per million population (p. m. p. ). Of these patients, 62% were men, 54% were ≥65 years of age and 21% had diabetes mellitus as primary renal disease (PRD), and 84% had haemodialysis (HD), 11% had peritoneal dialysis (PD) and 5% had pre-emptive kidney transplantation as an initial treatment modality. The overall prevalence of RRT on 31 December 2019 was 893 p. m. p. , with 58% of patients on HD, 5% on PD and 37% living with a kidney transplant. The overall kidney transplant rate was 35 p. m. p. and 29% of the kidney grafts were from a living donor. The unadjusted 5-year survival probability was 42. 3% for patients commencing dialysis, 86. 6% for recipients of deceased donor grafts and 94. 4% for recipients of living donor grafts in the period 2010-14. When comparing age categories, there were substantial differences in the distribution of PRD, treatment modality and kidney donor type, and in the survival probabilities.
Derechos:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original.
Lengua:	Anglès
Documento:	Article ; recerca ; Versió publicada
Materia:	Dialysis ; Epidemiology ; ESRD ; Graft survival ; Kidney transplantation ; Patient survival
Publicado en:	Clinical Kidney Journal, Vol. 15 (december 2021) , p. 452-472, ISSN 2048-8513

DOI: 10.1093/ckj/sfab273
PMID: 35211303

21 p, 4.9 MB

El registro aparece en las colecciones:
Documentos de investigación > Documentos de los grupos de investigación de la UAB > Centros y grupos de investigación (producción científica) > Ciencias de la salud y biociencias > Institut de Recerca Sant Pau
Artículos > Artículos de investigación
Artículos > Artículos publicados